Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CYB pseudogene 2 (MTCYBP2) is classified as a mitochondrial pseudogene related to the mitochondrially encoded cytochrome b gene (MT-CYB) but does not encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events and typically accumulate mutations that prevent them from encoding active gene products. Unlike the functional MT-CYB gene, which is part of mitochondrial complex III and is essential for oxidative phosphorylation[1][4][7], MTCYBP2 has no known coding potential or established biological role. There is no evidence it serves as a therapeutic target, biomarker, or has relevance in human disease. Its appearance in some gene lists may reflect annotation of non-functional genomic elements, not functional or druggable targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CYB pseudogene 2 (MTCYBP2).